Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gabapentin for Relapse Prevention: Alcohol Withdrawal Effects

NCT02349477 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT02349477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02349477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gabapentin for Relapse Prevention: Alcohol Withdrawal Effects
Lead sponsor
Medical University of South Carolina
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2014
Completion date
August 27, 2018
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, alcohol withdrawal